Rocuronium Bromide Injection — FDA Drug Shortage

Current — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status Current. The shortage was first posted on Feb 15, 2023.

Shortage details

Status
Current
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-4200-6
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)
Initial Posting
Feb 15, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.